| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.32 | 0.06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |